文献速递系统性红斑狼疮血管炎

STING缺陷在狼疮和动脉粥样硬化小鼠模型改善中的作用

Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis.
PubMed 文献 · Arthritis Rheumatol · 2024-12-19

本研究在Toll样受体7驱动的狼疮小鼠模型和动脉粥样硬化小鼠模型中探讨STING的作用,发现STING缺陷可减轻狼疮样表型、血管损伤和动脉粥样硬化负荷,并减少I型干扰素产生,作者认为STING抑制在SLE治疗中具有治疗潜力,但需进一步研究机制和可行性。

要点

  • 在IMQ诱导的TLR7驱动狼疮模型中,Sting1-/-小鼠较野生型小鼠疾病严重程度降低。
  • STING缺陷可减轻血管损伤并减少动脉粥样硬化负荷,伴随I型干扰素产生减少。
  • 作者认为STING及下游干扰素反应在TLR7驱动自身免疫中具致病作用,支持STING抑制的治疗潜力。

核心结论

  • STING及下游干扰素反应在TLR7驱动的自身免疫、血管损伤和动脉粥样硬化中具致病作用,支持STING抑制在SLE治疗中的治疗潜力。
  • 需进一步研究以阐明STING参与这些过程的机制,并探索靶向STING作为SLE及相关自身免疫病治疗策略的可行性。

研究设计与样本

  • 在B6背景野生型和Sting1-/-小鼠中使用咪喹莫特诱导TLR7驱动的狼疮模型,评估器官受累、血清自身抗体及固有和适应性免疫应答。
  • 将Sting1-/-小鼠回交至载脂蛋白E敲除(Apoe-/-)小鼠,Apoe-/-和Apoe-/-Sting1-/-小鼠均喂食高脂饲料诱导动脉粥样硬化并进行表型评估。

主要发现

  • 与IMQ处理的野生型小鼠相比,Sting1-/-小鼠狼疮样表型疾病严重程度降低,表现为脾肿大减轻、肾脏免疫复合物沉积和肾损伤减少、髓系细胞扩增减弱以及T和B淋巴细胞活化降低。
  • IMQ诱导的与IFN-β产生相关的DNA释放及随后的干扰素诱导反应在Sting1-/-小鼠中减弱。
  • DNase I治疗减轻野生型小鼠中IMQ诱导的促炎反应,但在Sting1-/-小鼠中无效果。
  • STING缺陷提供对血管损伤的保护并减少动脉粥样硬化负荷,伴随I型干扰素产生减少。
  • 用人I型干扰素处理的人单核细胞来源巨噬细胞较未处理细胞显著内化更多乙酰化低密度脂蛋白,而在人SLE中发现氧化核酸与疾病活动度和血管损伤之间存在关联。

局限性

  • 需进一步研究以阐明STING参与这些过程的机制,并探索靶向STING作为SLE及相关自身免疫病治疗策略的可行性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome characterized by autoreactive responses to nucleic acids, dysregulation of the type I interferon (IFN-I) pathway, and accelerated atherosclerosis. The stimulator of IFN genes (STING), a cytosolic DNA sensor, has pathogenic implications in various inflammatory diseases. However, its specific role in SLE pathogenesis, particularly in tissue damage, remains unclear. This study aimed to elucidate the role of STING in murine models of Toll-like receptor 7 (TLR7)-driven lupus and atherosclerosis. METHODS: A TLR7-driven lupus model was induced using imiquimod (IMQ) in wild-type (WT) and STING knockout (Sting1-/-) mice on a B6 background. Mice were assessed for organ involvement, serum autoantibodies, and innate and adaptive immune responses. Additionally, Sting1-/- mice were backcrossed to apolipoprotein E knockout (Apoe-/-) mice, and both Apoe-/- and Apoe-/-Sting1-/- mice were fed a high-fat chow diet to induce atherosclerosis. Phenotypic assessments were conducted. RESULTS: Compared with IMQ-treated WT mice, Sting1-/- mice exhibited reduced disease severity in the lupus-like phenotype, characterized by decreased splenomegaly, lower renal immune complex deposition and renal damage, diminished expansion of myeloid cells, and reduced activation of T and B lymphocytes. IMQ-induced DNA release associated with IFN-β production and subsequent IFN-induced responses were attenuated in Sting1-/- mice. DNase I treatment mitigated IMQ-induced proinflammatory responses in WT mice but had no effect in Sting1-/- mice. Furthermore, STING deficiency conferred protection against vascular damage and reduced atherosclerosis burden, accompanied by decreased IFN-I production. Human monocyte-derived macrophages treated with IFN-I significantly internalized more acetylated low-density lipoprotein when compared with untreated cells, whereas an association between oxidized nucleic acids and disease activity and vascular damage was found in human SLE. CONCLUSION: These findings highlight a pathogenic role of STING and downstream IFN responses in TLR7-driven autoimmunity, vascular damage and atherosclerosis, supporting a therapeutic potential for STING inhibition in SLE treatment. Further research is warranted to elucidate the mechanisms underlying STING's involvement in these processes and to explore the feasibility of targeting STING as a therapeutic strategy in SLE and related autoimmune disorders.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Carmona-Rivera C, Seto NL, et al. Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis. Arthritis Rheumatol. 2024. PMID: 39605244. doi:10.1002/art.43062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。